Share

All Updates

March 1, 2022
Colorado

A virtual event held by ACS CAN and U.S. Sen. Michael Bennet highlighted the promise of new blood-based cancer screening technologies that have the potential to dramatically increase early-stage diagnosis for a wide range of cancers and called on Congress to pass the Multi-Cancer Early Detection Screening Coverage (MCED) Act.

February 28, 2022

Nearly 100 cancer organizations representing patients, providers and researchers sent a letter to the president and congressional leadership in support of funding the Cancer Moonshot initiative

February 28, 2022

Nearly 100 cancer organizations representing patients, providers and researchers sent a letter to the president and congressional leadership in support of funding the Cancer Moonshot initiative

February 28, 2022
Indiana

INDIANAPOLIS, IN. – “Today, the House of Representatives approved legislation that puts the health of Hoosier kids at greater risk. “Lowering the tax rate on some e-cigarettes by 40% and approving a weight-based tax for the tobacco industry’s newest and lightest products is a setback for public health. “Tobacco

February 25, 2022
Wyoming

The Wyoming Senate on Friday failed to adopt an amendment authorizing Gov. Mark Gordon to embark on Medicaid expansion negotiations with the federal government, effectively ending Medicaid expansion efforts for the legislative session. R.J. Ours, the government relations director for the American Cancer Society Cancer Action Network (ACS CAN), released the following statement in reaction.

February 24, 2022
Kansas

The Kansas legislature left Topeka without adequately addressing several critical issues affecting access to health care for tens of thousands of Kansans, particularly those in need of cancer screening and treatment.

February 24, 2022
Arizona

The House of Representatives passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. House Bill 2144 aims to enable more Arizonans to benefit from biomarker testing, a critical step in accessing precision medicine treatments.

February 24, 2022
Arizona

The House of Representatives passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. House Bill 2144 aims to enable more Arizonans to benefit from biomarker testing, a critical step in accessing precision medicine treatments.

February 24, 2022
Missouri

Statement from American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director Emily Kalmer JEFFERSON CITY, MO. - “Today, the Missouri House passed legislation, HJR 117, that could send the issue of expanded access to healthcare coverage back to the statewide ballot. Expanding coverage for Missourians has